Exiqon A/S Interim report for the period 1 January

Interim report for the period 1 January - 30 June 2008 (unaudited)

Strong organic growth continued in Q2 2008 supported by new research product
offerings. The development of Exiqon's first molecular diagnostic product based
on miRNA profiling remains on track for year end launch. 

See the full Interim report in the attached pdf-fil

Exiqon A/S Interim report for the period 1 January - 30 June 2008 (unaudited)

Attachments